Search

Edison Scientific announced an agreement with Pfizer to apply Kosmos, its AI scientist, across Pfizer's biopharmaceutical research and development pipeline (press release dated October 30, 2026). Terms are not stated in the excerpt. www.bio

Flagship Pioneering announced on 29 October 2026 the formation of Etcelera, created by merging the platforms of Cellarity, Etiome and Empress Therapeutics with Flagship's in-house AI. Ad Rawcliffe leads it. The platform combines human trans

A Hong Kong Baptist University team (corresponding author Lu Zhang) posted the bioRxiv preprint "Illuminating phage dark matter beyond the reach of structural alignments with PhageFlare" on 29 October 2026, not yet peer reviewed. PhageFlare

Barcelona-based ALLOX closed a US$10.5m (EUR 9.4m) seed round led by Asabys (Sabadell Asabys II), with CDTI (SICC Innvierte) and the Institut Catala de Finances, and appointed Morten Graugaard independent board chair. Proceeds scale its hig

Phileo by Lesaffre and Chile-founded PhageLab announced a strategic partnership to deliver bacteriophage-based products against poultry pathogens such as Salmonella and pathogenic E. coli, starting in Latin America. Phileo's bacteriophage p

Gary Brixi and Brian Hie's teams report that the genome language model Evo 2 can learn from a few examples placed in its prompt (in-context learning, no retraining) and use them to generate proteins, de novo antibodies, CRISPR-Cas9 loci, mi

Anthropic highlighted 20 scientific foundations, institutions and research groups it has partnered with in an expansion of its AI for Science program, which gives free Claude credits to researchers on high-impact projects (October 28, 2026)

BioGeometry, a Beijing-based AI-native biopharma company, announced its Series A+ financing, taking Series A funding above US$100 million, to develop its GeoFlow molecular and GeoCell cellular world models and automated labs (October 28, 20

Formation Bio announced its debut Drug Development Accelerator Fund with $600 million in capital commitments, intended to acquire 10-15 drug programs over the next 3-5 years and advance them through clinical milestones using its AI-native d

Paul Tetteh Asare and colleagues report that a GtrB-like glycosyltransferase influences cell-surface properties and infection by phage BCP8-2 in Bacillus cereus. Their study links reduced phage adsorption to altered bacterial surfaces, part

DDDBench Core is a live leaderboard of 59 drug discovery and development benchmarks, selected from 302 in Insilico Medicine's Foundations set, comparing generalist frontier models with Insilico's compact specialist MMAI models; the page lis

Swiss tech-bio firm Atlas Bio launched from stealth with a $10 million seed round led by Creandum and a previously unannounced pre-seed led by First Momentum Ventures and LEA Partners, $12.5 million in total. Its foundation model, trained o

In this 42-minute German-language podcast, ZHAW microbiologist Lars Fieseler speaks with Jean-Daniel Strub about phage specificity, applications in food production and how phage resistance differs from antibiotic resistance. The episode was

Pythia Labs announced its launch on October 27, 2026 alongside a bioRxiv preprint introducing Pythia-1, an all-atom generative model that designed full-length human IgGs across 22 targets, including GPCR agonist and antagonist antibodies. T

Anthropic reports that over several months its scientists have worked with six organizations developing new medicines (BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group) and have b

Divergence Labs published a preprint with Anthropic describing an agentic design campaign with Claude toward a biparatopic antibody that physically removes IgE bound to its receptor FcεRI, as a food-allergy therapy candidate. Of 91 experime

Boston-based Tremont AI, spun out of the Mahmood Lab at Mass General Brigham, announced a research collaboration with AstraZeneca to develop and evaluate AI solutions for accelerated safety screening in preclinical toxicologic pathology stu

Healio reports (October 26, 2026) on the Pittsburgh Phage Program's seven-year review presented by Ghady Haidar at IDWeek 2026 (Washington, October 21-24). From November 2019 to April 2026 the program received 357 phage requests, 347 of whi

The UK AI Security Institute reports that pretraining data filtering is effective and selective as a safeguard for open-weight protein models, but not necessarily durable against fine-tuning (October 26, 2026). www.aisi.gov.uk

An open-access practical guide to annotating tailed phage genomes, from assembly checks and phage-aware gene calling to conservative functional assignments. The authors explain why automated outputs need manual review, how gene context and